Search
deen

Economic Sectors

White paper on the engagement of private equity investors in the outpatient medical market

Our white pa­per "Pri­vate equity in­ves­tors in the Ger­man out­pa­ti­ent mar­ket" pro­vi­des an over­view of the re­gu­latory chal­len­ges and cur­rent PE ac­tivi­ties in the out­pa­ti­ent me­di­cal mar­ket. It also in­clu­des state­ments on tran­sac­tion ac­tivity and re­gu­latory den­sity in the va­rious me­di­cal spe­cial­ties.​

The Ger­man health­care mar­ket has been of great in­te­rest to na­tio­nal and in­ter­na­tio­nal pri­vate equity in­ves­tors for many years: a stable eco­no­mic star­ting po­si­tion and good pro­spects for the fu­ture lead to in­cre­asing tran­sac­tion ac­tivity. Since 2015, the out­pa­ti­ent me­di­cal mar­ket in par­ti­cu­lar has also been in the fo­cus of many in­ves­tors, as the re­gu­latory frame­work since then has made it pos­si­ble to con­cen­trate on cer­tain spe­cia­list di­sci­plines. In re­cent years, pri­vate equity in­ves­tors have the­re­fore in­cre­asin­gly brought to­ge­ther out­pa­ti­ent me­di­cal fa­ci­li­ties in large struc­tures as part of so-cal­led "buy-and-build" pro­ces­ses.

White paper on the engagement of private equity investors in the outpatient medical market© Adobe Stock
Dr. Sarah Gersch-Souvignet, Jannis Pulm, 14.01.2021 back to top

Related Topics

RSM Eb­ner Stolz ad­vi­ses Oak­ley Ca­pi­tal on the ac­qui­si­tion of a ma­jo­rity stake in Web­cen­tral in a carve-out from its pa­rent com­pany

The as­surance and con­sul­ting firm RSM Eb­ner Stolz has ad­vi­sed Oak­ley Ca­pi­tal (Oak­ley) on the buyer side of the ac­qui­si­tion of a ma­jo­rity stake, alongs­ide co-in­ves­tors, in Web­cen­tral DEH (Web­cen­tral) th­rough a carve-out from its Aus­tra­lian Se­cu­ri­ties Ex­change (ASX) lis­ted pa­rent com­pany Web­cen­tral Li­mited.  ...read more

M&A as an op­tion for me­dium-si­zed com­pa­nies

We are cur­rently see­ing a re­vi­val in the M&A en­viron­ment. This is par­ti­cu­larly evi­dent in the in­cre­asing num­ber of tran­sac­tion as­si­gn­ments we are hand­ling, both on the buyer and sel­ler side, for cor­po­rate cli­ents as well as for fi­nan­cial in­ves­tors in the mid-mar­ket en­viron­ment. What is the cur­rent state of the M&A mar­ket and how can we sup­port you prag­ma­ti­cally and ef­fi­ci­ently from a sin­gle source in an up­com­ing tran­sac­tion?  ...read more

Eb­ner Stolz sup­ports SYZ Ca­pi­tal and Sa­tur­nus Ca­pi­tal on the ac­qui­si­tion of a ma­jo­rity stake in SK Pharma Lo­gistics GmbH

The au­diting and con­sul­ting firm Eb­ner Stolz has sup­por­ted SYZ Ca­pi­tal and Sa­tur­nus Ca­pi­tal on the ac­qui­si­tion of SK Pharma Lo­gistics GmbH (SK Pharma) with a com­pre­hen­sive fi­nan­cial and tax due di­li­gence and, to­ge­ther with Swiss Ne­xia part­ner ADB Alt­dor­fer Duss & Beil­stein AG, with the tax struc­tu­ring of the tran­sac­tion.  ...read more